首页> 外文期刊>The Journal of Urology >Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
【24h】

Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.

机译:肾外肿瘤扩展的位置不会影响pT3a肾细胞癌患者的生存。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: The current TNM classification for pathological pT3a renal cell carcinoma includes patients with perinephric or sinus fat invasion, suggesting that the prognoses are similar for these pathological findings. However, sinus fat invasion was proposed by some investigators to be an independent predictor of inferior cancer specific outcome following surgical treatment. To assess and improve the predictive ability of the current pT3a primary tumor classification we evaluated the prognostic significance of location of extrarenal tumor extension on cancer specific survival following surgery. MATERIALS AND METHODS: The database of 3,470 patients at our institution who were treated for renal cell carcinoma from 1990 to 2006 was searched for those with pT3a tumors managed by partial or radical nephrectomy. Patients with nonrenal cell carcinoma histology, direct adrenal invasion or a followup of less then 6 months were excluded from analyses. The prognostic importance of all clinical and pathological variables was investigated using Cox proportional hazards regression. RESULTS: A total of 365 patients with pT3a renal cell carcinoma and a mean followup of 33.5 months (range 6.1 to 158.6) met study inclusion criteria and they comprise the data set for this analysis. There was no difference in 5-year cancer specific survival between 166 patients (45.5%) with SF invasion and 199 (54.5%) with PF invasion only (50.8% and 54.1%, p = 0.782 respectively). On univariate analyses neither sinus fat invasion nor the location of extrarenal extension, assessed as perinephric fat vs sinus fat vs perinephric plus sinus fat, correlated with cancer specific survival following surgical treatment (HR 1.052, p = 0.783 and HR 1.072, p = 0.543, respectively). After adjusting for the effects of nodal and systemic metastases tumor grade and sarcomatoid differentiation remained independent predictors of renal cell carcinoma specific survival in our pT3a cohort of patients (HR 1.508, p = 0.003 and HR 1.810, p = 0.018, respectively).CONCLUSIONS: In contrast to previously reported observations, in our cohort of surgically treated patients with pT3a renal cell carcinoma the location of extrarenal extension was not an important prognosticator of cancer specific mortality. Based on our findings we confirm that perinephric and/or sinus fat should be similarly subclassified in the primary tumor staging system.
机译:目的:目前针对病理性pT3a肾细胞癌的TNM分类包括有肾周性或窦性脂肪浸润的患者,这表明这些病理发现的预后相似。然而,一些研究者认为鼻窦脂肪浸润是手术治疗后癌症特异性转归的独立预测因子。为了评估和改善当前pT3a原发性肿瘤分类的预测能力,我们评估了肾外肿瘤扩展位置对手术后癌症特异性存活的预后意义。材料与方法:检索1990年至2006年间在我院接受治疗的3470例肾细胞癌患者的数据库,以查找部分或根治性肾切除术治疗的pT3a肿瘤患者。非肾细胞癌组织学检查,直接肾上腺浸润或随访少于6个月的患者均排除在分析之外。使用Cox比例风险回归分析了所有临床和病理变量的预后重要性。结果:总共365例pT3a肾细胞癌患者,平均随访33.5个月(范围6.1至158.6),符合研究纳入标准,构成了该分析的数据集。 166例SF浸润(45.5%)和199例PF浸润(199.5%)的5年癌症特异性生存率无差异(分别为50.8%和54.1%,p = 0.782)。在单因素分析中,鼻窦脂肪与鼻窦脂肪对比会阴肾与鼻窦加鼻窦脂肪之间的关系,无论是窦内脂肪浸润还是肾外扩展位置,均与手术治疗后的癌症特异性存活率相关(HR 1.052,p = 0.783和HR 1.072,p = 0.543,分别)。在调整了淋巴结转移和全身转移的影响后,我们的pT3a患者队列中肿瘤等级和肉瘤样分化仍是肾细胞癌特异性生存的独立预测因子(HR 1.508,p = 0.003和HR 1.810,p = 0.018)。与先前报道的观察结果相反,在我们的接受手术治疗的pT3a肾细胞癌患者队列中,肾外延伸的位置并不是癌症特异性死亡率的重要预后指标。根据我们的发现,我们确认在原发性肿瘤分期系统中,肾上腺和/或窦性脂肪也应类似地分类。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号